{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T10:40:25Z","timestamp":1756377625079,"version":"3.44.0"},"reference-count":14,"publisher":"BMJ","issue":"2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2021,1,28]]},"published-print":{"date-parts":[[2021,2]]},"abstract":"<jats:p>The management of infections caused by carbapenem-resistant organisms has been a challenge. We report a rare emergence of resistance to the novel beta-lactam\/ beta-lactamase combination ceftolozane\/tazobactam by <jats:italic>Klebsiella pneumoniae<\/jats:italic>, causing urinary tract infection. The <jats:italic>K. pneumoniae<\/jats:italic>, in this case, was reported to be sensitive to the other novel beta-lactam\/ beta-lactamase combination of ceftazidime\/avibactam. The timely administration of ceftazidime\/avibactam resulted in prompt clinical resolution of the urinary tract infection caused by an extensively drug-resistant <jats:italic>K. pneumoniae<\/jats:italic>.<\/jats:p>","DOI":"10.1136\/bcr-2020-240351","type":"journal-article","created":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T16:19:53Z","timestamp":1612541993000},"page":"e240351","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["A rare emergence of resistance to ceftolozane\/tazobactam in <i>Klebsiella pneumoniae<\/i> causing urinary tract infection"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3824-1657","authenticated-orcid":false,"given":"Antony","family":"Arumairaj","sequence":"first","affiliation":[{"name":"Internal Medicine, Metropolitan Hospital Center, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanket","family":"Agarwal","sequence":"additional","affiliation":[{"name":"Internal Medicine, Metropolitan Hospital Center, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarun","family":"Popli","sequence":"additional","affiliation":[{"name":"Infectious Disease, Metropolitan Hospital Center, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eliana","family":"Lopez","sequence":"additional","affiliation":[{"name":"Infectious Disease, Metropolitan Hospital Center, New York, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,2,5]]},"reference":[{"key":"2025082802584195000_14.2.e240351.1","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25061340","article-title":"Resistance of gram-negative bacteria to current antibacterial agents and approaches to resolve it","volume":"25","author":"Breijyeh","year":"2020","journal-title":"Molecules"},{"key":"2025082802584195000_14.2.e240351.2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.00296-11"},{"key":"2025082802584195000_14.2.e240351.3","doi-asserted-by":"crossref","DOI":"10.3390\/antibiotics9020058","article-title":"Ceftazidime\/Avibactam and Ceftolozane\/Tazobactam for multidrug-resistant gram negatives in patients with hematological malignancies: current experiences","volume":"9","author":"Criscuolo","year":"2020","journal-title":"Antibiotics"},{"key":"2025082802584195000_14.2.e240351.4","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2017.01230"},{"key":"2025082802584195000_14.2.e240351.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2014.01.007"},{"key":"2025082802584195000_14.2.e240351.6","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw593"},{"key":"2025082802584195000_14.2.e240351.7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fpubh.2019.00151","article-title":"The \"Old\" and the \"New\" Antibiotics for MDR Gram-Negative Pathogens: For Whom, When, and How","volume":"7","author":"Karaiskos","year":"2019","journal-title":"Front Public Health"},{"key":"2025082802584195000_14.2.e240351.8","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.913352"},{"key":"2025082802584195000_14.2.e240351.9","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-013-0168-2"},{"key":"2025082802584195000_14.2.e240351.10","first-page":"1","article-title":"In Vivo Resistance to Ceftolozane\/Tazobactam in Pseudomonas aeruginosa Arising by AmpC- and Non-AmpC-Mediated Pathways","volume":"2018","author":"Skoglund","year":"2018","journal-title":"Case Rep Infect Dis"},{"key":"2025082802584195000_14.2.e240351.11","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01183-17","article-title":"Emergence of Ceftolozane-Tazobactam-Resistant Pseudomonas aeruginosa during Treatment Is Mediated by a Single AmpC Structural Mutation","volume":"61","author":"MacVane","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2025082802584195000_14.2.e240351.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2017.06.007"},{"key":"2025082802584195000_14.2.e240351.13","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw243"},{"key":"2025082802584195000_14.2.e240351.14","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02183-19","article-title":"Carbapenem-Resistant gram-negative bacterial infections in children","volume":"64","author":"Aguilera-Alonso","year":"2020","journal-title":"Antimicrob Agents Chemother"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-240351","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T09:58:47Z","timestamp":1756375127000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-240351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":14,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,2,5]]},"published-print":{"date-parts":[[2021,2]]}},"alternative-id":["10.1136\/bcr-2020-240351"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-240351","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2021,2]]}}}